Chronic Fatigue Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be at least 18 years old.
- You have been diagnosed (by yourself or a doctor) with Long COVID, ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome), and/or POTS (Postural Orthostatic Tachycardia Syndrome, a condition affecting heart rate when standing up).
- You are interested in tools to help manage symptoms of Long COVID, ME/CFS, and/or POTS.
- You either own a wearable device (such as a fitness tracker or smartwatch) that you are willing to use for the study, or you are happy to use a device provided by the study team.
- You agree to wear the device for the whole study, share its data with the research team, and sync the data at least once a week.
- You have access to a smartphone or tablet to sync your wearable device and view feedback from it.
- You agree to let the study know if you are taking part in other treatments or studies related to Long COVID, ME/CFS, or POTS.
- You agree to complete at least 75% of the surveys sent to you during the study.
Who may not be able to join:
- There are no specific exclusion criteria — as long as you meet all of the requirements above, there is nothing that would automatically prevent you from joining.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0000000000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Objective 1:Assess the effect of study-provided devices and enhanced educational materials to manage Long COVID-19 symptom severity, compared to general educational materials alone using data from participants survey responses.; Primary Objective 2: Collate a unique longitudinal dataset combining patients' demographics, symptoms, symptom severity, quality of life, and sensor data including sleep, activity, heart rate, heart rate variability, and Body Battery.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.